Hepatitis B Virus Infection clinical trials

Explore recruiting hepatitis b virus infection clinical trials.

Recruiting hepatitis b virus infection studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Hepatitis B Virus Infection trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A Platform Study Evaluating the Efficacy and Safety of Investigational Therapies in Participants with Chronic Hepatitis B Infection (PREVAIL)

France, Romania

Therapeutic exploratory (Phase II) EU CTIS Study details

Pomalidomide in people with chronic hepatitis B virus (HBV) infection: Safety and immune-enhancing effects (The PIPPI Study)

Denmark

Phase I and Phase II (Integrated)- Other EU CTIS Study details

A Phase 2 Study to Evaluate the Safety, Tolerability, and Efficacy of Regimens Containing VIR-2218, VIR-3434, and/or PEG-IFNα in Subjects with Chronic Hepatitis B Virus Infection

Romania, Germany

Therapeutic exploratory (Phase II) EU CTIS Study details

Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AB-101 Following Oral Administration in Healthy and Chronic Hepatitis B Subjects

Romania, Italy, Bulgaria

Human Pharmacology (Phase I)- First administration to humans EU CTIS Study details

A Randomized, Double-Blind, Active-Controlled Multicenter Phase 2 Study Evaluating the Efficacy and Safety of ALG-000184 Compared with Tenofovir Disoproxil Fumarate in Untreated HBeAg-Positive and HBeAg-Negative Adult Subjects with Chronic Hepatitis B Virus Infection (B-SUPREME)

Spain, Italy, Bulgaria, Romania, France

Therapeutic exploratory (Phase II) EU CTIS Study details

A Randomized, Double-Blind Evaluation of the Pharmacokinetics, Safety, and Antiviral Efficacy of Tenofovir Alafenamide (TAF) in Children and Adolescent Subjects with Chronic Hepatitis B Virus Infection

Romania

Therapeutic exploratory (Phase II) EU CTIS Study details

Hepatitis B Virus Infection trials by city

Hepatitis B Virus Infection in Toronto Hepatitis B Virus Infection in Vancouver Hepatitis B Virus Infection in Montreal Hepatitis B Virus Infection in Calgary Hepatitis B Virus Infection in Edmonton Hepatitis B Virus Infection in Ottawa Hepatitis B Virus Infection in Winnipeg Hepatitis B Virus Infection in Quebec City Hepatitis B Virus Infection in Hamilton Hepatitis B Virus Infection in Kitchener Hepatitis B Virus Infection in London Hepatitis B Virus Infection in Halifax Hepatitis B Virus Infection in New York Hepatitis B Virus Infection in Los Angeles Hepatitis B Virus Infection in Chicago Hepatitis B Virus Infection in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease